| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 4.4 | 5.1 | 4.2 |
| Other income | 0.1 | 0.1 | 0.2 |
| Total income | 4.5 | 5.2 | 4.3 |
| Profit before exceptional items & tax | 0.2 | 0.4 | 0.3 |
| Profit before tax | 0.2 | 0.4 | 0.3 |
| Net profit | 0.1 | 0.3 | 0.2 |
| Operating margin | 4.4% | 7.7% | 7.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -50.00% |
|---|---|
| Net profit, quarter on quarter | -66.70% |
| Revenue, year on year | +4.80% |
BSE results filing, BSE: 544220. Figures extracted from the filing.
Clinitech Laboratory Ltd: key numbers
- Share price
- ₹33.65
- Market cap
- ₹7.68 Cr
- Revenue (annual)
- ₹9.49 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 18.4×Sector 34.2×
- Promoter holding
- 64.20%
- FII holding
- 0.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clinitech Laboratory Ltd
All →Clinitech Laboratory Annual General Meeting
Clinitech Laboratory Limited held its 16th Annual General Meeting on September 24, 2026. Shareholders transacted items including financial statement adoption and director re-appointment.
Clinitech Laboratory Annual General Meeting
Clinitech Laboratory Limited has released its Annual Report for FY 2025-26 and notice for the Annual General Meeting to be held on September 24, 2026.
Clinitech Laboratory Board Meeting Outcome
Clinitech Laboratory Limited's board approved the FY 2025-26 report and convened its 16th Annual General Meeting. The meeting also finalized book closure dates and appointed a voting scrutinizer.
Clinitech Laboratory Board Meeting Date
Clinitech Laboratory Ltd scheduled a Board Meeting for August 17, 2026. The board will discuss director appointments and the 16th AGM.
Clinitech Laboratory Fund Raise of ₹5.78 Cr
Clinitech Laboratory Ltd reported zero deviation in the utilization of INR 578.30 Lakhs raised through its IPO. Funds were deployed primarily for diagnostic center expansion.
- Value
- ₹5.78 Cr
Clinitech Laboratory Board Meeting Outcome
Clinitech Laboratory Limited approved audited standalone and consolidated financial results for FY 2025-26. The board also reviewed internal audits and approved related party transactions for FY 2026-27.